Scilex Holding (SCLXW) Net Cash Flow (2020 - 2026)

Scilex Holding (SCLXW) recorded quarterly Net Cash Flow of $1.1 million in Q1 2026, down 77.57% quarter-over-quarter from $4.8 million in Q4 2025, and down 57.12% on a YoY basis from $2.5 million in Q1 2025.

Scilex Holding (SCLXW) Net Cash Flow (2020 - 2026) Analysis & Trends

Scilex Holding's Net Cash Flow history runs 7 years deep, the most recent figure standing at $1.1 million for Q1 2026.

  • In Q1 2026, Net Cash Flow fell 57.12% year-over-year to $1.1 million; the TTM figure through Mar 2026 stood at $995000.0 (down 67.12% YoY), while the FY2025 annual figure was $2.4 million, up 267.4% from the prior year.
  • Net Cash Flow was $1.1 million for Q1 2026 at Scilex Holding, down from $4.8 million in the prior quarter.
  • In the past five years, Net Cash Flow ranged from a high of $30.1 million in Q2 2023 to a low of -$33.1 million in Q3 2023.
  • Historically, Net Cash Flow has averaged $144529.4 across 5 years, with a median of -$299000.0 in 2022.
  • Biggest YoY gain for Net Cash Flow was 9813.22% in 2022; the steepest drop was 11419.18% in 2022.
  • A 5-year view of Net Cash Flow shows it stood at -$299000.0 in 2022, then surged by 1019.4% to $2.7 million in 2023, then slumped by 276.21% to -$4.8 million in 2024, then jumped by 199.77% to $4.8 million in 2025, then slumped by 77.57% to $1.1 million in 2026.
  • The last three Net Cash Flow figures came in at $1.1 million (Q1 2026), $4.8 million (Q4 2025), and -$3.3 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Cash Flow (Qtr)
1 Gsk 93,699,046.73 Bn 93,699,041.77 Bn 7.76 Bn 210.32 Mn
2 Eli Lilly 1,012.06 Bn 1,006.77 Bn 16.22 Bn -2.05 Bn
3 Johnson & Johnson 560.67 Bn 538.62 Bn 15.96 Bn 2.00 Bn
4 AbbVie 402.20 Bn 392.85 Bn 10.78 Bn 4.17 Bn
5 Merck 298.59 Bn 292.94 Bn 12.09 Bn -9.27 Bn
6 Amgen 188.77 Bn 176.74 Bn 5.87 Bn 2.91 Bn
7 Gilead Sciences 160.22 Bn 152.49 Bn 5.52 Bn 75.00 Mn
8 Pfizer 148.19 Bn 135.42 Bn -1.21 Bn 544.00 Mn
9 Bristol Myers Squibb 116.72 Bn 106.26 Bn 8.07 Bn -587.00 Mn
10 Scilex Holding - - 4.15 Mn 1.08 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 1.08 Mn
Mar 31, 2026 1.08 Mn
Dec 31, 2025 4.83 Mn
Dec 31, 2025 4.83 Mn
Sep 30, 2025 -3.26 Mn
Sep 30, 2025 -3.26 Mn
Jun 30, 2025 -1.66 Mn
Jun 30, 2025 -1.66 Mn
Mar 31, 2025 2.53 Mn
Mar 31, 2025 2.53 Mn
Dec 31, 2024 -4.84 Mn
Dec 31, 2024 -4.84 Mn
Sep 30, 2024 -1.55 Mn
Sep 30, 2024 -1.55 Mn
Jun 30, 2024 6.89 Mn
Jun 30, 2024 6.89 Mn
Mar 31, 2024 -1.96 Mn
Mar 31, 2024 -1.96 Mn
Dec 31, 2023 2.75 Mn
Dec 31, 2023 2.75 Mn